AAP
COLL icon

Arax Advisory Partners’s Collegium Pharmaceutical COLL Stock Holding History

Arax Advisory Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.1K Buy
1,605
+1,359
+552% +$57.5K ﹤0.01% 1633
2025
Q4 		$11.4K Buy
246
+4
+2% +$167 ﹤0.01% 2400
2025
Q3 		$8.47K Sell
242
-1,754
-88% -$61K ﹤0.01% 2672
2025
Q2 		$59K Buy
+1,996
New +$56.9K ﹤0.01% 1156
2025
Q1 		– Sell
-108
Closed -$3.1K – 2740
2024
Q4 		$3.1K Sell
108
-47
-30% -$1.55K ﹤0.01% 1898
2024
Q3 		$5.99K Hold
155
– – ﹤0.01% 1640
2024
Q2 		$4.99K Buy
+155
New +$5.37K ﹤0.01% 1595

Other funds holding COLL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return